nse,bse,nseindia,nse india,share price,stock price,stock value,shares prices,share prices,stock quote,stock prices, share prices, corporate announcements,board meetings,corporate actions,dividends,agm,stock split,bonus

Sun Pharmaceuticals Industries Limited (NSE India Code : SUNPHARMA) BUY

Company Name :

Enter Company Name or NSE Code

SUNPHARMA Technical Levels

Resistance 2		706.30
Resistance 1		702.00
PIVOT		697.65
Support 1		693.35
Support 2		684.70

SUNPHARMA Fundamentals

Earning Growth		26.56%
Profit Margin		77.15
PE		41.61
EPS		15.20
Quarter		30-Sep-11

SUNPHARMA Futures

Close
Contracts Traded
Open Interest(OI)
Change in OI
Lot Size		500

SUNPHARMA Options

Most Active Call		720
Most Active Put		680
Highest OI Call		700
Highest OI Put		660
Expiry Date		19-Oct-12

SUNPHARMA Technical Levels

Other Stocks from Pharmaceuticals Sector AARTIDRUGS ABBOTINDIA AJANTPHARM ALCHEM ALKALI ALPA AMRUTANJAN ANKURDRUGS ARL ASTRAZEN AUROPHARMA AVENTIS BALPHARMA BIOCON BLISSGVS CADILAHC CELESTIAL CIPLA DISHMAN DIVISLAB DRREDDY ELDERPHARM FDC FKONCO GLAXO GLENMARK GRANULES INDOCO INDSWFTLAB INDSWFTLTD IPCALAB JAGSNPHARM JBCHEPHARM JUBILANT KILITCH KOPRAN LUPIN LYKALABS MANGALAM MERCK MOREPENLAB NATCOPHARM NECLIFE NEULANDLAB OPTOCIRCUI ORCHIDCHEM PANACEABIO PARABDRUGS PFIZER PIRHEALTH

Sponsored Advertisement

SUNPHARMA Share Price on 5-10-2012

Open		700
High		700.85
Low		580
Close		682.55
Volume		1509580
Change		-16.2 (-2.32%)

Series		EQ
Date of Listing		08-Feb-95
Paid Up Value		1
Face Value		1
Market Capital		25647.1 Crores
52 Week High/Low		705 / 448.5

Sponsored Advertisement

Sun Pharmaceuticals Industries Limited Company Profile

Sun Pharma (SUNPHARMA) is into specialty pharmaceuticals and active pharmaceutical ingredients. The company operates in select therapeutic segments like psychiatry, neurology, cardiology and gastroenterology. As many as eight bulk actives and 18 processes for DMFs have been developed and scaled up. In all, the company has received seven DMFs and nine EDMFs. The company doubled its capacity and the area at the bulk active site in Panoli. With the completion of this expansion, 269,000 sq. ft. area has been added to the plant thereby offering additional 129 KL reactor capacity for the regulated markets. The company plans to work on various technologies in NDDS and work on specific therapy areas for NCE. For products that are differentiated for the medium term, it would continue to work on technologically complex products such as liposome delivery systems, microspheres based delivery systems and controlled release technologies.

SUNPHARMA Intraday Realtime Chart

SUNPHARMA Corporate Announcements

DATE	PURPOSE
06-Aug-12	Record Date
01-Aug-12	Disclosure under SEBI Takeover Regulations
31-Jul-12	Press Release
02-Jul-12	Disclosure under SEBI Takeover Regulations
01-Jun-12	Disclosure under SEBI Takeover Regulations

SUNPHARMA Corporate Actions

DATE	PURPOSE
14-Aug-12	INTERIM DIVIDEND
02-Sep-11	Annual General Meeting And Dividend Rs.3.50 Per Share
02-Sep-11	AGM/DIV-RS.3.50 PER SHARE

SUNPHARMA Board Meetings

MEETING DATE	PURPOSE
10-Aug-12	Results/Dividend
10-Aug-12	Un-audited Financial Results
29-May-12	Results/Dividend
13-Feb-12	Un-audited Financial Results
13-Nov-11	Un-audited Financial Results

SUNPHARMA Related companies

Symbol	Company Name
AARTIDRUGS	Aarti Drugs Limited
ABBOTINDIA	Abbott India Limited
AJANTPHARM	Ajanta Pharma Limited
ALCHEM	Alchemist Limited
ALKALI	Alkali Metals Limited

Most Active NSE INDIA Stocks

HDFC LITL IVRCLINFRA HDIL UNITECH JPASSOCIAT GVKPIL TATAMOTORS IFCI IBREALEST ESSAROIL GMRINFRA BIRLAPOWER HINDALCO BHEL RENUKA RCOM DLF SUZLON RELCAPITAL IDFC ADANIENT ITC TATAPOWER BALLARPUR

Free Stock Market Tips:

What is an Option contract?

Home	Stock Market	IPO	Mutual Funds	Education	Paid Service
About us	Share Market	IPO Watch	MF News	IPO	Subscription
VJonDalalStreet	Technical Analysis	New IPO Review	Old Funds	Articles	Equity Performance
DalalStreet Blog	Stock Market News	Indian IPO News	New Funds	Stock Market	Futures Performance
Free Sms Alerts	World Stock Market	IPO Allotment Status	Best Funds	Financial Terms	Options Performance
Privacy	Stock Recommendations	Grey Market Premium	MF Analysis	Futures & Options	Jackpot Performance

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither VJonDalalStreet.com website nor any of its promoters shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes acceptance of our Disclaimer